TherapeuticsMD Announces Patent Updates for ANNOVERA®
On September 8, 2020, the United States Patent and Trademark Office (USPTO) issued its second ANNOVERA patent (U.S. Patent No.
- On September 8, 2020, the United States Patent and Trademark Office (USPTO) issued its second ANNOVERA patent (U.S. Patent No.
- In addition, based on recent communications from the USPTO, a third ANNOVERA patent (U.S. Patent No.
- These additional patents, which cover different aspects of ANNOVERA, provide independent layers of patent protection, said Robert Finizio, TherapeuticsMD Chief Executive Officer.
- To learn more about TherapeuticsMD, please visit www.therapeuticsmd.com or follow us on Twitter: @TherapeuticsMD and on Facebook: TherapeuticsMD.